CEO and executive chairman appointed at iPierian
This article was originally published in Scrip
Executive Summary
iPierian, a biopharmaceutical company, has appointed Dr Nancy Stagliano CEO, while the company's interim CEO, Dr Peter van Vlasselaer will become executive chairman of the board of directors. Dr Stagliano joins iPierian after serving as CEO and co-founder of CytomX Therapeutics.